Meadow Brook Investment Advisors LLC Astrazeneca PLC Transaction History
Meadow Brook Investment Advisors LLC
- $106 Billion
- Q2 2024
A detailed history of Meadow Brook Investment Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 31 shares of AZN stock, worth $2,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 31
-0.0%
Holding current value
$2,575
Previous $2.1 Million
15.14%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...